Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone

Molecular imaging offers unprecedented opportunities for investigating dynamic changes underlying neuropsychiatric conditions. Here, we evaluated whether [11C]ABP688, a positron emission tomography (PET) ligand that binds to the allosteric site of the metabotropic glutamate receptor type 5 (mGluR5),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cerebral blood flow and metabolism 2015-07, Vol.35 (7), p.1169-1174
Hauptverfasser: Zimmer, Eduardo R, Parent, Maxime J, Leuzy, Antoine, Aliaga, Antonio, Aliaga, Arturo, Moquin, Luc, Schirrmacher, Esther S, Soucy, Jean-Paul, Skelin, Ivan, Gratton, Alain, Gauthier, Serge, Rosa-Neto, Pedro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1174
container_issue 7
container_start_page 1169
container_title Journal of cerebral blood flow and metabolism
container_volume 35
creator Zimmer, Eduardo R
Parent, Maxime J
Leuzy, Antoine
Aliaga, Antonio
Aliaga, Arturo
Moquin, Luc
Schirrmacher, Esther S
Soucy, Jean-Paul
Skelin, Ivan
Gratton, Alain
Gauthier, Serge
Rosa-Neto, Pedro
description Molecular imaging offers unprecedented opportunities for investigating dynamic changes underlying neuropsychiatric conditions. Here, we evaluated whether [11C]ABP688, a positron emission tomography (PET) ligand that binds to the allosteric site of the metabotropic glutamate receptor type 5 (mGluR5), is sensitive to glutamate fluctuations after a pharmacological challenge. For this, we used ceftriaxone (CEF) administration in rats, an activator of the GLT-1 transporter (EAAT2), which is known to decrease extracellular levels of glutamate. MicroPET [11C]ABP688 dynamic acquisitions were conducted in rats after a venous injection of either saline (baseline) or CEF 200 mg/kg (challenge). Binding potentials (BPND) were obtained using the simplified reference tissue method. Between-condition statistical parametric maps indicating brain regions showing the highest CEF effects guided placement of microdialysis probes for subsequent assessment of extracellular levels of glutamate. The CEF administration increased [11C]ABP688 BPND in the thalamic ventral anterior (VA) nucleus bilaterally. Subsequent microdialysis assessment revealed declines in extracellular glutamate concentrations in the VA. The present results support the concept that availability of mGluR5 allosteric binding sites is sensitive to extracellular concentrations of glutamate. This interesting property of mGluR5 allosteric binding sites has potential applications for assessing the role of glutamate in the pathogenesis of neuropsychiatric conditions.
doi_str_mv 10.1038/jcbfm.2015.35
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1038_jcbfm.2015.35</sage_id><sourcerecordid>1701503516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-2054d537aec45b7aa21a0f638cfa1806312104d23506479fc3eac3170f47ac1f3</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_Agit1Wj14l4KUUZvteMklmPQjbwa6FhXqoIhQJb7OZ2Szzo05mqv73znZrqSJ4yiEfvi95X8ZeIUwRZHa6dauingpANZXqCZugUrPEAOqnbALCYKJN9uWAHca4BYBMKvWcHQiVgTYgJuz6oqYyNCUPDf8cblu-qIaeauo9P68G1w_Uh7aJ_HvoN_waMf86P_uos-wtn_PF8ipBnm-oqnxT-r3JfdF3gX60jX_BnhVURf_y_jxin87fX-UfkuXl4iKfLxOnlOwTASpdK2nIu1StDJFAgkLLzBWE4zslCoR0LaQCnZpZ4aQnJ9FAkRpyWMgj9m6fezOsar92vuk7quxNF2rqftqWgv3zpgkbW7a3NtXpbkVjwPF9QNd-G3zsbR2i81VFjW-HaMdZqEAq1P-neiaMEphmI33zF922Q9eMm7hTAMpoMapkr1zXxtj54uHdCHbXsL1r2O4atlKN_vXjzz7o35WO4GQPIpX-0ch_pv0Cy6StMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1692005762</pqid></control><display><type>article</type><title>Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone</title><source>Access via SAGE</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zimmer, Eduardo R ; Parent, Maxime J ; Leuzy, Antoine ; Aliaga, Antonio ; Aliaga, Arturo ; Moquin, Luc ; Schirrmacher, Esther S ; Soucy, Jean-Paul ; Skelin, Ivan ; Gratton, Alain ; Gauthier, Serge ; Rosa-Neto, Pedro</creator><creatorcontrib>Zimmer, Eduardo R ; Parent, Maxime J ; Leuzy, Antoine ; Aliaga, Antonio ; Aliaga, Arturo ; Moquin, Luc ; Schirrmacher, Esther S ; Soucy, Jean-Paul ; Skelin, Ivan ; Gratton, Alain ; Gauthier, Serge ; Rosa-Neto, Pedro</creatorcontrib><description>Molecular imaging offers unprecedented opportunities for investigating dynamic changes underlying neuropsychiatric conditions. Here, we evaluated whether [11C]ABP688, a positron emission tomography (PET) ligand that binds to the allosteric site of the metabotropic glutamate receptor type 5 (mGluR5), is sensitive to glutamate fluctuations after a pharmacological challenge. For this, we used ceftriaxone (CEF) administration in rats, an activator of the GLT-1 transporter (EAAT2), which is known to decrease extracellular levels of glutamate. MicroPET [11C]ABP688 dynamic acquisitions were conducted in rats after a venous injection of either saline (baseline) or CEF 200 mg/kg (challenge). Binding potentials (BPND) were obtained using the simplified reference tissue method. Between-condition statistical parametric maps indicating brain regions showing the highest CEF effects guided placement of microdialysis probes for subsequent assessment of extracellular levels of glutamate. The CEF administration increased [11C]ABP688 BPND in the thalamic ventral anterior (VA) nucleus bilaterally. Subsequent microdialysis assessment revealed declines in extracellular glutamate concentrations in the VA. The present results support the concept that availability of mGluR5 allosteric binding sites is sensitive to extracellular concentrations of glutamate. This interesting property of mGluR5 allosteric binding sites has potential applications for assessing the role of glutamate in the pathogenesis of neuropsychiatric conditions.</description><identifier>ISSN: 0271-678X</identifier><identifier>EISSN: 1559-7016</identifier><identifier>DOI: 10.1038/jcbfm.2015.35</identifier><identifier>PMID: 25806702</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Animals ; Carbon Radioisotopes - metabolism ; Ceftriaxone - pharmacology ; Excitatory Amino Acid Transporter 2 - metabolism ; Glutamic Acid - analysis ; Glutamic Acid - metabolism ; Original ; Oximes - metabolism ; Positron-Emission Tomography ; Pyridines - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptor, Metabotropic Glutamate 5 - metabolism ; Thalamus - metabolism</subject><ispartof>Journal of cerebral blood flow and metabolism, 2015-07, Vol.35 (7), p.1169-1174</ispartof><rights>2015 ISCBFM</rights><rights>Copyright Nature Publishing Group Jul 2015</rights><rights>Copyright © 2015 International Society for Cerebral Blood Flow &amp; Metabolism, Inc. 2015 International Society for Cerebral Blood Flow &amp; Metabolism, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-2054d537aec45b7aa21a0f638cfa1806312104d23506479fc3eac3170f47ac1f3</citedby><cites>FETCH-LOGICAL-c553t-2054d537aec45b7aa21a0f638cfa1806312104d23506479fc3eac3170f47ac1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640271/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640271/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,21819,27924,27925,43621,43622,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25806702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zimmer, Eduardo R</creatorcontrib><creatorcontrib>Parent, Maxime J</creatorcontrib><creatorcontrib>Leuzy, Antoine</creatorcontrib><creatorcontrib>Aliaga, Antonio</creatorcontrib><creatorcontrib>Aliaga, Arturo</creatorcontrib><creatorcontrib>Moquin, Luc</creatorcontrib><creatorcontrib>Schirrmacher, Esther S</creatorcontrib><creatorcontrib>Soucy, Jean-Paul</creatorcontrib><creatorcontrib>Skelin, Ivan</creatorcontrib><creatorcontrib>Gratton, Alain</creatorcontrib><creatorcontrib>Gauthier, Serge</creatorcontrib><creatorcontrib>Rosa-Neto, Pedro</creatorcontrib><title>Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone</title><title>Journal of cerebral blood flow and metabolism</title><addtitle>J Cereb Blood Flow Metab</addtitle><description>Molecular imaging offers unprecedented opportunities for investigating dynamic changes underlying neuropsychiatric conditions. Here, we evaluated whether [11C]ABP688, a positron emission tomography (PET) ligand that binds to the allosteric site of the metabotropic glutamate receptor type 5 (mGluR5), is sensitive to glutamate fluctuations after a pharmacological challenge. For this, we used ceftriaxone (CEF) administration in rats, an activator of the GLT-1 transporter (EAAT2), which is known to decrease extracellular levels of glutamate. MicroPET [11C]ABP688 dynamic acquisitions were conducted in rats after a venous injection of either saline (baseline) or CEF 200 mg/kg (challenge). Binding potentials (BPND) were obtained using the simplified reference tissue method. Between-condition statistical parametric maps indicating brain regions showing the highest CEF effects guided placement of microdialysis probes for subsequent assessment of extracellular levels of glutamate. The CEF administration increased [11C]ABP688 BPND in the thalamic ventral anterior (VA) nucleus bilaterally. Subsequent microdialysis assessment revealed declines in extracellular glutamate concentrations in the VA. The present results support the concept that availability of mGluR5 allosteric binding sites is sensitive to extracellular concentrations of glutamate. This interesting property of mGluR5 allosteric binding sites has potential applications for assessing the role of glutamate in the pathogenesis of neuropsychiatric conditions.</description><subject>Animals</subject><subject>Carbon Radioisotopes - metabolism</subject><subject>Ceftriaxone - pharmacology</subject><subject>Excitatory Amino Acid Transporter 2 - metabolism</subject><subject>Glutamic Acid - analysis</subject><subject>Glutamic Acid - metabolism</subject><subject>Original</subject><subject>Oximes - metabolism</subject><subject>Positron-Emission Tomography</subject><subject>Pyridines - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Metabotropic Glutamate 5 - metabolism</subject><subject>Thalamus - metabolism</subject><issn>0271-678X</issn><issn>1559-7016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0c9rFDEUB_Agit1Wj14l4KUUZvteMklmPQjbwa6FhXqoIhQJb7OZ2Szzo05mqv73znZrqSJ4yiEfvi95X8ZeIUwRZHa6dauingpANZXqCZugUrPEAOqnbALCYKJN9uWAHca4BYBMKvWcHQiVgTYgJuz6oqYyNCUPDf8cblu-qIaeauo9P68G1w_Uh7aJ_HvoN_waMf86P_uos-wtn_PF8ipBnm-oqnxT-r3JfdF3gX60jX_BnhVURf_y_jxin87fX-UfkuXl4iKfLxOnlOwTASpdK2nIu1StDJFAgkLLzBWE4zslCoR0LaQCnZpZ4aQnJ9FAkRpyWMgj9m6fezOsar92vuk7quxNF2rqftqWgv3zpgkbW7a3NtXpbkVjwPF9QNd-G3zsbR2i81VFjW-HaMdZqEAq1P-neiaMEphmI33zF922Q9eMm7hTAMpoMapkr1zXxtj54uHdCHbXsL1r2O4atlKN_vXjzz7o35WO4GQPIpX-0ch_pv0Cy6StMA</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Zimmer, Eduardo R</creator><creator>Parent, Maxime J</creator><creator>Leuzy, Antoine</creator><creator>Aliaga, Antonio</creator><creator>Aliaga, Arturo</creator><creator>Moquin, Luc</creator><creator>Schirrmacher, Esther S</creator><creator>Soucy, Jean-Paul</creator><creator>Skelin, Ivan</creator><creator>Gratton, Alain</creator><creator>Gauthier, Serge</creator><creator>Rosa-Neto, Pedro</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20150701</creationdate><title>Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone</title><author>Zimmer, Eduardo R ; Parent, Maxime J ; Leuzy, Antoine ; Aliaga, Antonio ; Aliaga, Arturo ; Moquin, Luc ; Schirrmacher, Esther S ; Soucy, Jean-Paul ; Skelin, Ivan ; Gratton, Alain ; Gauthier, Serge ; Rosa-Neto, Pedro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-2054d537aec45b7aa21a0f638cfa1806312104d23506479fc3eac3170f47ac1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Carbon Radioisotopes - metabolism</topic><topic>Ceftriaxone - pharmacology</topic><topic>Excitatory Amino Acid Transporter 2 - metabolism</topic><topic>Glutamic Acid - analysis</topic><topic>Glutamic Acid - metabolism</topic><topic>Original</topic><topic>Oximes - metabolism</topic><topic>Positron-Emission Tomography</topic><topic>Pyridines - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Metabotropic Glutamate 5 - metabolism</topic><topic>Thalamus - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zimmer, Eduardo R</creatorcontrib><creatorcontrib>Parent, Maxime J</creatorcontrib><creatorcontrib>Leuzy, Antoine</creatorcontrib><creatorcontrib>Aliaga, Antonio</creatorcontrib><creatorcontrib>Aliaga, Arturo</creatorcontrib><creatorcontrib>Moquin, Luc</creatorcontrib><creatorcontrib>Schirrmacher, Esther S</creatorcontrib><creatorcontrib>Soucy, Jean-Paul</creatorcontrib><creatorcontrib>Skelin, Ivan</creatorcontrib><creatorcontrib>Gratton, Alain</creatorcontrib><creatorcontrib>Gauthier, Serge</creatorcontrib><creatorcontrib>Rosa-Neto, Pedro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cerebral blood flow and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zimmer, Eduardo R</au><au>Parent, Maxime J</au><au>Leuzy, Antoine</au><au>Aliaga, Antonio</au><au>Aliaga, Arturo</au><au>Moquin, Luc</au><au>Schirrmacher, Esther S</au><au>Soucy, Jean-Paul</au><au>Skelin, Ivan</au><au>Gratton, Alain</au><au>Gauthier, Serge</au><au>Rosa-Neto, Pedro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone</atitle><jtitle>Journal of cerebral blood flow and metabolism</jtitle><addtitle>J Cereb Blood Flow Metab</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>35</volume><issue>7</issue><spage>1169</spage><epage>1174</epage><pages>1169-1174</pages><issn>0271-678X</issn><eissn>1559-7016</eissn><abstract>Molecular imaging offers unprecedented opportunities for investigating dynamic changes underlying neuropsychiatric conditions. Here, we evaluated whether [11C]ABP688, a positron emission tomography (PET) ligand that binds to the allosteric site of the metabotropic glutamate receptor type 5 (mGluR5), is sensitive to glutamate fluctuations after a pharmacological challenge. For this, we used ceftriaxone (CEF) administration in rats, an activator of the GLT-1 transporter (EAAT2), which is known to decrease extracellular levels of glutamate. MicroPET [11C]ABP688 dynamic acquisitions were conducted in rats after a venous injection of either saline (baseline) or CEF 200 mg/kg (challenge). Binding potentials (BPND) were obtained using the simplified reference tissue method. Between-condition statistical parametric maps indicating brain regions showing the highest CEF effects guided placement of microdialysis probes for subsequent assessment of extracellular levels of glutamate. The CEF administration increased [11C]ABP688 BPND in the thalamic ventral anterior (VA) nucleus bilaterally. Subsequent microdialysis assessment revealed declines in extracellular glutamate concentrations in the VA. The present results support the concept that availability of mGluR5 allosteric binding sites is sensitive to extracellular concentrations of glutamate. This interesting property of mGluR5 allosteric binding sites has potential applications for assessing the role of glutamate in the pathogenesis of neuropsychiatric conditions.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>25806702</pmid><doi>10.1038/jcbfm.2015.35</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0271-678X
ispartof Journal of cerebral blood flow and metabolism, 2015-07, Vol.35 (7), p.1169-1174
issn 0271-678X
1559-7016
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640271
source Access via SAGE; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Carbon Radioisotopes - metabolism
Ceftriaxone - pharmacology
Excitatory Amino Acid Transporter 2 - metabolism
Glutamic Acid - analysis
Glutamic Acid - metabolism
Original
Oximes - metabolism
Positron-Emission Tomography
Pyridines - metabolism
Rats
Rats, Sprague-Dawley
Receptor, Metabotropic Glutamate 5 - metabolism
Thalamus - metabolism
title Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A24%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imaging%20in%20Vivo%20Glutamate%20Fluctuations%20with%20%5B11C%5DABP688:%20A%20GLT-1%20Challenge%20with%20Ceftriaxone&rft.jtitle=Journal%20of%20cerebral%20blood%20flow%20and%20metabolism&rft.au=Zimmer,%20Eduardo%20R&rft.date=2015-07-01&rft.volume=35&rft.issue=7&rft.spage=1169&rft.epage=1174&rft.pages=1169-1174&rft.issn=0271-678X&rft.eissn=1559-7016&rft_id=info:doi/10.1038/jcbfm.2015.35&rft_dat=%3Cproquest_pubme%3E1701503516%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1692005762&rft_id=info:pmid/25806702&rft_sage_id=10.1038_jcbfm.2015.35&rfr_iscdi=true